High-Tech-Gründerfonds, the Germany state- and corporate-backed fund, and the Thüringen Foundation for Technology Innovation, and Research [Stift] have invested €700,000 ($1m) in JeNaCell, a biomaterial spin-off of the Friedrich Schiller University Jena (FSU), on 12 October.
JeNaCell’s biomaterial (pictured) can be used for making medical and cosmetic products, suitable for treating poorly healing wounds, as well having applications for wellness products and technology, the company said.
Martin Pfister, investment manager of High-Tech Gründerfonds, said: “JeNaCell’s developments not only in modifiable…
